LVTX
LAVA Therapeutics NV · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website lavatherapeutics.com
- Employees(FY) 69
- ISIN NL0015000AG6
Performance
-0.32%
1W
+14.02%
1M
+79.65%
3M
+127.21%
6M
+95.57%
YTD
+71.67%
1Y
Profile
LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer patients. Its lead clinical-stage candidates are LAVA-051, which is in Phase 1/2a clinical trial for blood cancers, including chronic lymphocytic leukemia, multiple myeloma, and acute myeloid leukemia; and LAVA-1207 that is in Phase 1/2a clinical trial for metastatic castration-resistant prostate cancer. The company is also developing other Gammabody drug candidates, which include LAVA-1223, which targets the epidermal growth factor receptor (EGFR) for the treatment of selected solid tumors, as well as LAVA-1266 and LAVA-1278, which are preclinical candidates for the treatment of various hematologic malignancies. LAVA Therapeutics N.V. has a research collaboration and license agreement with Janssen Biotech, Inc. for the potential discovery and development of multi-specific antibody products that are directed to a specified target in various fields of use; and a collaboration with Merck & Co., Inc. to evaluate anti-PD-1 therapy KEYTRUDA in combination with LAVA-1207. The company was incorporated in 2016 and is headquartered in Utrecht, the Netherlands.
Technical Analysis of LVTX 2024-05-10
Overview:
In analyzing the technical indicators for LVTX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for potential invest...
Recent News & Updates
- 2024-05-06 04:05
- 2024-03-20 00:52
- 2024-03-19 19:00
- 2024-03-04 19:30
- 2024-03-04 18:30
- 2024-01-24 18:00
- 2023-11-15 18:00
- 2023-09-05 19:11
- 2023-08-21 19:00
- 2023-08-13 19:00
- 2023-06-13 21:00
- 2023-06-07 19:00
- 2023-06-01 04:20
- 2023-05-31 20:09
- 2023-05-30 05:28
LAVA Announces Annual Meeting of Shareholders(Yahoo Finance)
- 2023-04-10 19:00
- 2023-03-08 19:05
- 2023-02-15 18:00
- 2023-02-08 18:00
- 2023-02-05 18:00
- 2023-01-22 18:00
- 2023-01-06 00:07
- 2023-01-02 18:00
- 2022-12-09 21:00
- 2022-11-16 03:05
- 2022-11-03 04:05
- 2022-11-02 21:00
- 2022-10-31 19:00
- 2022-10-06 23:00
- 2022-09-25 20:00
Page 1 of 3
previousnext